These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15911284)

  • 1. Discovery of selective aldo-keto reductase ligands--an on-bead assay strategy.
    Dixon S; Robins L; Elling RA; Liu R; Lam KS; Wilson DK; Kurth MJ
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2938-42. PubMed ID: 15911284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a role for a mouse sperm surface aldo-keto reductase (AKR1B7) and its human analogue in the detoxification of the reactive aldehyde, acrolein.
    Jagoe WN; Howe K; O'Brien SC; Carroll J
    Andrologia; 2013 Oct; 45(5):326-31. PubMed ID: 22970857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldose and aldehyde reductase in animal tissues.
    Flynn TG
    Metabolism; 1986 Apr; 35(4 Suppl 1):105-8. PubMed ID: 3083200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of binding constants and molecular modelling of inhibitors in the active sites of aldose reductase and aldehyde reductase.
    Carbone V; Zhao HT; Chung R; Endo S; Hara A; El-Kabbani O
    Bioorg Med Chem; 2009 Feb; 17(3):1244-50. PubMed ID: 19121944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All in the family: aldose reductase and closely related aldo-keto reductases.
    Petrash JM
    Cell Mol Life Sci; 2004 Apr; 61(7-8):737-49. PubMed ID: 15094999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning, sequencing, and enzymatic activity of an inducible aldo-keto reductase from Chinese hamster ovary cells.
    Hyndman DJ; Takenoshita R; Vera NL; Pang SC; Flynn TG
    J Biol Chem; 1997 May; 272(20):13286-91. PubMed ID: 9148949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Merging the binding sites of aldose and aldehyde reductase for detection of inhibitor selectivity-determining features.
    Steuber H; Heine A; Podjarny A; Klebe G
    J Mol Biol; 2008 Jun; 379(5):991-1016. PubMed ID: 18495158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-ray structure of the V301L aldo-keto reductase 1B10 complexed with NADP(+) and the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.
    Ruiz FX; Cousido-Siah A; Mitschler A; Farrés J; Parés X; Podjarny A
    Chem Biol Interact; 2013 Feb; 202(1-3):178-85. PubMed ID: 23295227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of C7 modifications on benzothiadiazine-1,1-dioxide derivatives on their inhibitory activity and selectivity toward aldose reductase.
    Zhang S; Chen X; Parveen S; Hussain S; Yang Y; Jing C; Zhu C
    ChemMedChem; 2013 Apr; 8(4):603-13. PubMed ID: 23136050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A vertebrate aldo-keto reductase active with retinoids and ethanol.
    Crosas B; Cederlund E; Torres D; Jornvall H; Farres J; Pares X
    J Biol Chem; 2001 Jun; 276(22):19132-40. PubMed ID: 11278684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel homodimeric and heterodimeric rat gamma-hydroxybutyrate synthases that associate with the Golgi apparatus define a distinct subclass of aldo-keto reductase 7 family proteins.
    Kelly VP; Sherratt PJ; Crouch DH; Hayes JD
    Biochem J; 2002 Sep; 366(Pt 3):847-61. PubMed ID: 12071861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism.
    Crosas B; Hyndman DJ; Gallego O; Martras S; Parés X; Flynn TG; Farrés J
    Biochem J; 2003 Aug; 373(Pt 3):973-9. PubMed ID: 12732097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1.7 A structure of FR-1, a fibroblast growth factor-induced member of the aldo-keto reductase family, complexed with coenzyme and inhibitor.
    Wilson DK; Nakano T; Petrash JM; Quiocho FA
    Biochemistry; 1995 Nov; 34(44):14323-30. PubMed ID: 7578036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The xylose reductase (AKR2B5) structure: homology and divergence from other aldo-keto reductases and opportunities for protein engineering.
    Wilson DK; Kavanagh KL; Klimacek M; Nidetzky B
    Chem Biol Interact; 2003 Feb; 143-144():515-21. PubMed ID: 12604237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalytic mechanism and substrate selectivity of aldo-keto reductases: insights from structure-function studies of Candida tenuis xylose reductase.
    Kratzer R; Wilson DK; Nidetzky B
    IUBMB Life; 2006 Sep; 58(9):499-507. PubMed ID: 17002977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional studies of aldo-keto reductases in Saccharomyces cerevisiae.
    Chang Q; Griest TA; Harter TM; Petrash JM
    Biochim Biophys Acta; 2007 Mar; 1773(3):321-9. PubMed ID: 17140678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor selectivity between aldo-keto reductase superfamily members AKR1B10 and AKR1B1: role of Trp112 (Trp111).
    Zhang L; Zhang H; Zhao Y; Li Z; Chen S; Zhai J; Chen Y; Xie W; Wang Z; Li Q; Zheng X; Hu X
    FEBS Lett; 2013 Nov; 587(22):3681-6. PubMed ID: 24100137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of new inhibitors of aldo-keto reductase 1C1 by structure-based virtual screening.
    Brozic P; Turk S; Lanisnik Rizner T; Gobec S
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):245-50. PubMed ID: 18765269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sepiapterin reductase and ALR2 ("aldose reductase") from bovine brain.
    Dowling TG; O'Rourke JF; Tipton KF
    Adv Exp Med Biol; 1993; 328():313-24. PubMed ID: 8493908
    [No Abstract]   [Full Text] [Related]  

  • 20. Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites.
    El-Kabbani O; Wilson DK; Petrash M; Quiocho FA
    Mol Vis; 1998 Sep; 4():19. PubMed ID: 9756955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.